Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
John M. Mulvaney, MHA
Articles
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)
E. Thomas Carey, PharmD;Ryan A. Forrey, MS;Douglas Haughs, BS;Dawn Moore Jefferson, PharmD;James A. Jorgenson, RPh, MS;Derek M. McMichael, PharmD;John M. Mulvaney, MHA;Susan M. Spivey, Phar
December 11th 2011The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
Read More
Utility of the PhaSeal Closed System Drug Transfer Device
Derek M. McMichael, PharmD;Dawn Moore Jefferson, PharmD;E. Thomas Carey, PharmD;Ryan A. Forrey, PharmD, MS;Susan M. Spivey, PharmD, DDS;John M. Mulvaney, MHA;James A. Jorgenson, RPh, MS;R.
February 2nd 2011The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.
Read More
Latest Updated Articles
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
